Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC42812Angiotensinogen (1-14) (human) (trifluoroacetate salt)纯度: >95.00%
A synthetic peptide precursor of angiotensin I
- GC42869Atpenin A5CAS: 119509-24-9纯度: >95.00%
A specific inhibitor of mitochondrial complex II enzymes
- GC42871Atrial Natriuretic Peptide (1-28) (rat) (trifluoroacetate salt)纯度: >97.50%
An atrial natriuretic peptide
- GC42872Atrial Natriuretic Peptide (3-28) (human) (trifluoroacetate salt)纯度: >95.00%
An atrial natriuretic peptide
- GC42924Beraprost (sodium salt)CAS: 88475-69-8纯度: >98.00%
A stable, orally active analog of prostacyclin
- GC42930Big Endothelin-1 (1-38) (human) (trifluoroacetate salt)纯度: >95.00%
A peptide precursor of endothelin-1
- GC42941Bis(methylthio)gliotoxinCAS: 74149-38-5纯度: >95.00%
A fungal metabolite with diverse biological activities
- GC42970Brain Natriuretic Peptide (1-32) (human) (trifluoroacetate salt)纯度: >95.00%
A peptide with cardiovascular functions
- GC43140Captopril DisulfideCAS: 64806-05-9纯度: >95.00%
A metabolite and degradation product of captopril
- GC43247Chlorthalidone Impurity GCAS: 16289-13-7纯度: >98.00%
A potential impurity in commercial chlorthalidone preparations
- GC43260Cholesteryl Linoleate Hydroperoxides纯度: >98.00%
Contains a mixture of racemic 9- and 13-HpODE cholesteryl esters
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC42812 | Angiotensinogen (1-14) (human) (trifluoroacetate salt) | - | >95.00% | |
A synthetic peptide precursor of angiotensin I | ||||
| GC42821 | AP219 | 779282-36-9 | >98.00% | |
A control compound for AP39 | ||||
| GC42869 | Atpenin A5 | 119509-24-9 | >95.00% | |
A specific inhibitor of mitochondrial complex II enzymes | ||||
| GC42871 | Atrial Natriuretic Peptide (1-28) (rat) (trifluoroacetate salt) | - | >97.50% | |
An atrial natriuretic peptide | ||||
| GC42872 | Atrial Natriuretic Peptide (3-28) (human) (trifluoroacetate salt) | - | >95.00% | |
An atrial natriuretic peptide | ||||
| GC42890 | Azelaoyl PAF | 354583-69-0 | >98.00% | |
A potent PPARγ agonist | ||||
| GC42913 | Benazeprilat | 86541-78-8 | >98.00% | |
An ACE inhibitor | ||||
| GC42924 | Beraprost (sodium salt) | 88475-69-8 | >98.00% | |
A stable, orally active analog of prostacyclin | ||||
| GC42930 | Big Endothelin-1 (1-38) (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide precursor of endothelin-1 | ||||
| GC42941 | Bis(methylthio)gliotoxin | 74149-38-5 | >95.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC42966 | Bopindolol (malonate) | 82857-38-3 | >98.00% | |
A β-adrenergic receptor antagonist | ||||
| GC42970 | Brain Natriuretic Peptide (1-32) (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide with cardiovascular functions | ||||
| GC42994 | Butanoyl PAF | 85405-03-4 | >98.00% | |
A PAF agonist that is present in oxLDL | ||||
| GC43062 | C2 Ceramide (d14:1/2:0) | 2097561-20-9 | >98.00% | |
A bioactive sphingolipid | ||||
| GC43136 | Campestanol | 474-60-2 | >98.00% | |
A phytosterol | ||||
| GC43140 | Captopril Disulfide | 64806-05-9 | >95.00% | |
A metabolite and degradation product of captopril | ||||
| GC43146 | Caspase-9 Inhibitor III (trifluoroacetate salt) | - | >95.00% | |
A caspase-9 inhibitor | ||||
| GC43160 | CAY10485 | 615264-62-5 | >98.00% | |
An ACAT-1 and -2 inhibitor with antioxidant activity | ||||
| GC43166 | CAY10535 | 945716-28-9 | >98.00% | |
A TPβ selective antagonist | ||||
| GC43180 | CAY10592 | 685139-10-0 | >98.00% | |
A selective partial PPARδ agonist | ||||
| GC43233 | CG 4305 | - | >95.00% | |
A stable PGI 2 analog with antithrombotic properties | ||||
| GC43242 | Chloramphenicol Succinate | 3544-94-3 | >99.00% | |
A prodrug form of chloramphenicol | ||||
| GC43247 | Chlorthalidone Impurity G | 16289-13-7 | >98.00% | |
A potential impurity in commercial chlorthalidone preparations | ||||
| GC43260 | Cholesteryl Linoleate Hydroperoxides | - | >98.00% | |
Contains a mixture of racemic 9- and 13-HpODE cholesteryl esters | ||||